Insider Trades63 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 56,000 | $12.51 | $1.2B | -16.68% | +93.20% | $700.6K | -5.81% | 10b5-1 | Sell Now |
| Jul 7, 2026 | Sell | MGTX | Stuart Naylor | CHIEF SCI OFCR, OPHTHALMOLOGY | 27,659 | $14.80 | $1.2B | -16.68% | +93.20% | $409.5K | -2.07% | 10b5-1 | Sell Now |
| May 27, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 7,000 | $9.89 | $1.2B | -16.68% | +93.20% | $69.2K | -0.72% | — | Sell Now |
| May 19, 2026 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 62,000 | $9.17 | $1.2B | -16.68% | +93.20% | $568.5K | -4.28% | 10b5-1 | Sell Now |
| Apr 21, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 56,000 | $10.22 | $1.2B | -16.68% | +93.20% | $572.3K | -5.45% | 10b5-1 | Sell Now |
| Apr 7, 2026 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 27,661 | $9.36 | $1.2B | -16.68% | +93.20% | $258.9K | -3.97% | 10b5-1 | Sell Now |
| Mar 24, 2026 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 62,000 | $7.41 | $1.2B | -16.68% | +93.20% | $459.4K | -4.10% | 10b5-1 | Sell Now |
| Feb 21, 2026 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 2,952 | $7.45 | $1.2B | -16.68% | +93.20% | $22.0K | -1.61% | — | Sell Now |
| Feb 21, 2026 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 5,949 | $7.45 | $1.2B | -16.68% | +93.20% | $44.3K | -7.98% | — | Sell Now |
| Feb 21, 2026 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 11,750 | $7.45 | $1.2B | -16.68% | +93.20% | $87.5K | -1.60% | — | Sell Now |
| Feb 21, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 31,726 | $7.45 | $1.2B | -16.68% | +93.20% | $236.4K | -2.83% | — | Sell Now |
| Feb 21, 2026 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 33,048 | $7.45 | $1.2B | -16.68% | +93.20% | $246.2K | -2.06% | — | Sell Now |
| Jan 17, 2026 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 13,951 | $7.42 | $1.2B | -16.68% | +93.20% | $103.5K | -6.42% | — | Sell Now |
| Jan 17, 2026 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 27,206 | $7.42 | $1.2B | -16.68% | +93.20% | $201.9K | -21.04% | — | Sell Now |
| Jan 17, 2026 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 35,250 | $7.42 | $1.2B | -16.68% | +93.20% | $261.6K | -4.44% | — | Sell Now |
| Jan 17, 2026 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 163,916 | $7.42 | $1.2B | -16.68% | +93.20% | $1.2M | -8.38% | — | Sell Now |
| Jan 17, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 163,916 | $7.42 | $1.2B | -16.68% | +93.20% | $1.2M | -11.13% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 4,364 | $7.73 | $1.2B | -16.68% | +93.20% | $33.7K | -12.97% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 6,729 | $7.73 | $1.2B | -16.68% | +93.20% | $52.0K | -4.37% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 7,814 | $7.73 | $1.2B | -16.68% | +93.20% | $60.4K | -5.07% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 17,625 | $7.73 | $1.2B | -16.68% | +93.20% | $136.2K | -2.67% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Richard Giroux | CFO & COO | 28,822 | $7.73 | $1.2B | -16.68% | +93.20% | $222.8K | -3.27% | — | Sell Now |
| Jan 7, 2026 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 34,074 | $7.73 | $1.2B | -16.68% | +93.20% | $263.4K | -2.49% | — | Sell Now |
| Dec 23, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 6,250 | $7.87 | $1.2B | -16.68% | +93.20% | $49.2K | -0.48% | — | Sell Now |
| Nov 20, 2025 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 5,000 | $7.43 | $1.2B | -16.68% | +93.20% | $37.1K | -16.05% | — | Sell Now |
| Oct 21, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 24,000 | $8.87 | $1.2B | -16.68% | +93.20% | $212.9K | -2.81% | 10b5-1 | Sell Now |
| Oct 7, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 47,500 | $8.39 | $1.2B | -16.68% | +93.20% | $398.5K | -3.49% | 10b5-1 | Sell Now |
| Jul 22, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 24,000 | $8.52 | $1.2B | -16.68% | +93.20% | $204.5K | -2.74% | 10b5-1 | Sell Now |
| Jul 8, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 47,500 | $7.97 | $1.2B | -16.68% | +93.20% | $378.6K | -3.37% | 10b5-1 | Sell Now |
| Jun 30, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 5,000 | $6.52 | $1.2B | -16.68% | +93.20% | $32.6K | -0.57% | — | Sell Now |
| Apr 22, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 24,000 | $6.00 | $1.2B | -16.68% | +93.20% | $144.0K | -2.65% | 10b5-1 | Sell Now |
| Apr 8, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 47,500 | $5.34 | $1.2B | -16.68% | +93.20% | $253.7K | -3.26% | 10b5-1 | Sell Now |
| Feb 21, 2025 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 5,903 | $7.30 | $1.2B | -16.68% | +93.20% | $43.1K | -3.75% | — | Sell Now |
| Feb 21, 2025 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 12,116 | $7.30 | $1.2B | -16.68% | +93.20% | $88.4K | -18.42% | — | Sell Now |
| Feb 21, 2025 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 23,500 | $7.30 | $1.2B | -16.68% | +93.20% | $171.6K | -3.37% | — | Sell Now |
| Feb 21, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 63,452 | $7.30 | $1.2B | -16.68% | +93.20% | $463.2K | -5.82% | — | Sell Now |
| Feb 21, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 66,095 | $7.30 | $1.2B | -16.68% | +93.20% | $482.5K | -4.01% | — | Sell Now |
| Jan 21, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 24,000 | $6.29 | $1.2B | -16.68% | +93.20% | $151.0K | -2.75% | 10b5-1 | Sell Now |
| Jan 14, 2025 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 2,909 | $5.77 | $1.2B | -16.68% | +93.20% | $16.8K | -12.29% | — | Sell Now |
| Jan 14, 2025 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 11,163 | $5.77 | $1.2B | -16.68% | +93.20% | $64.4K | -1.84% | — | Sell Now |
| Jan 14, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 13,219 | $5.77 | $1.2B | -16.68% | +93.20% | $76.3K | -1.49% | — | Sell Now |
| Jan 14, 2025 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 15,149 | $5.77 | $1.2B | -16.68% | +93.20% | $87.4K | -10.63% | — | Sell Now |
| Jan 14, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 15,863 | $5.77 | $1.2B | -16.68% | +93.20% | $91.5K | -1.12% | — | Sell Now |
| Jan 7, 2025 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 3,966 | $6.34 | $1.2B | -16.68% | +93.20% | $25.1K | -13.16% | — | Sell Now |
| Jan 7, 2025 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 6,886 | $6.34 | $1.2B | -16.68% | +93.20% | $43.7K | -5.32% | — | Sell Now |
| Jan 7, 2025 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 17,625 | $6.34 | $1.2B | -16.68% | +93.20% | $111.7K | -2.76% | — | Sell Now |
| Jan 7, 2025 | Sell | MGTX | Richard Giroux | CFO & COO | 27,760 | $6.34 | $1.2B | -16.68% | +93.20% | $176.0K | -2.95% | — | Sell Now |
| Jan 7, 2025 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 80,548 | $6.39 | $1.2B | -16.68% | +93.20% | $514.9K | -1.85% | 10b5-1 | Sell Now |
| May 28, 2024 | Sell | MGTX | Richard Giroux | CFO & COO | 3,000 | $5.14 | $1.2B | -16.68% | +93.20% | $15.4K | -0.36% | — | Sell Now |
| Apr 5, 2024 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 1,000 | $5.50 | $1.2B | -16.68% | +93.20% | $5.5K | -0.07% | — | Sell Now |
| Mar 12, 2024 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 2,000 | $6.07 | $1.2B | -16.68% | +93.20% | $12.1K | -0.15% | — | Sell Now |
| Feb 29, 2024 | Sell | MGTX | Richard Giroux | CFO & COO | 13,500 | $6.17 | $1.2B | -16.68% | +93.20% | $83.3K | -1.58% | — | Sell Now |
| Jan 14, 2024 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 2,644 | $6.36 | $1.2B | -16.68% | +93.20% | $16.8K | -2.15% | — | Sell Now |
| Jan 14, 2024 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 11,163 | $6.36 | $1.2B | -16.68% | +93.20% | $71.0K | -1.49% | — | Sell Now |
| Jan 14, 2024 | Sell | MGTX | Richard Giroux | CFO & COO | 13,219 | $6.36 | $1.2B | -16.68% | +93.20% | $84.1K | -0.87% | — | Sell Now |
| Jan 14, 2024 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 14,756 | $6.36 | $1.2B | -16.68% | +93.20% | $93.8K | -6.10% | — | Sell Now |
| Jan 14, 2024 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 15,863 | $6.36 | $1.2B | -16.68% | +93.20% | $100.9K | -0.78% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Robert J Wollin | GENERAL COUNSEL AND SECRETARY | 7,931 | $6.30 | $1.2B | -16.68% | +93.20% | $50.0K | -22.21% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 13,773 | $6.30 | $1.2B | -16.68% | +93.20% | $86.8K | -16.11% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Robert K Zeldin | CHIEF MEDICAL OFFICER | 18,507 | $6.30 | $1.2B | -16.68% | +93.20% | $116.6K | -15.36% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Stuart Naylor | CHIEF DEV. OFFICER | 54,050 | $6.41 | $1.2B | -16.68% | +93.20% | $346.7K | -4.46% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Richard Giroux | CFO & COO | 75,349 | $6.39 | $1.2B | -16.68% | +93.20% | $481.2K | -4.08% | — | Sell Now |
| Jan 7, 2024 | Sell | MGTX | Alexandria Forbes | PRESIDENT & CEO | 91,872 | $6.39 | $1.2B | -16.68% | +93.20% | $587.3K | -3.15% | — | Sell Now |